We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IDEX Q2 Earnings Surpass Estimates, Sales Increase Year Over Year
Read MoreHide Full Article
Key Takeaways
IEX reported Q2 adjusted EPS of $2.07 on $865.4M revenues, beating estimates and up 7% year over year.
HST segment sales surged 20% on strong organic growth and contributions from recent acquisitions.
IEX expects 2025 adjusted EPS of $7.85-$7.95 and organic sales growth of about 1%.
IDEX Corporation’s (IEX - Free Report) second-quarter 2025 adjusted earnings of $2.07 per share surpassed the Zacks Consensus Estimate of $2.00. The bottom line was relatively flat on a year-over-year basis. Management projected adjusted earnings to be in the band of $1.95-$2.05 per share in the quarter.
IEX’s Revenue Details
IDEX’s net sales of $865.4 million beat the Zacks Consensus Estimate of $857 million. The top line increased 7% year over year. Organic sales increased 1% year over year. While acquisitions/divestitures had a positive impact on sales of 5%, organic sales and foreign currency translation had a positive impact of 1% each on sales.
IEX reports net sales under three business segments, the results of which are discussed below:
Net sales from the Fluid & Metering Technologies segment totaled $310.9 million, down 3% year over year. Our estimate for segmental net sales was $312.2 million. Organic sales decreased 2% year over year. Acquisitions/divestitures had an adverse impact on sales of 2%, while foreign currency translation had a positive impact of 1% on sales.
Net sales from the Health & Science Technologies segment totaled $365.3 million, up 20% year over year. Our estimate for segmental net sales was $355.6 million. Organic sales increased 4% year over year. Acquisitions/divestitures and foreign currency translation had a positive impact of 15% and 1%, respectively, on sales.
Net sales from the Fire & Safety/Diversified Products segment totaled $191.5 million, which increased 3% year over year. Our estimate for segmental net sales was $188.4 million. Organic sales increased 2% on a year-over-year basis, while foreign currency translation had a favorable impact of 1% on sales.
IDEX Corporation Price, Consensus and EPS Surprise
IDEX’s cost of sales increased 7.4% year over year to $473.2 million. The adjusted gross profit was $392.2 million, up 6.9% year over year. The adjusted gross margin was 45.3% compared with 45.4% in the year-ago quarter.
Selling, general and administrative expenses increased 11.4% year over year to $203.6 million. Adjusted EBITDA was $237.2 million, up 5.7% from the year-ago quarter figure. The adjusted EBITDA margin decreased 40 bps year over year to 27.4%.
The operating income was $187.9 million, up 2.8% year over year. The operating margin was 21.7%, down 90 bps year over year. Interest expenses (net) increased 92.6% year over year to $15.6 million.
Balance Sheet and Cash Flow of IDEX
While exiting the second quarter, IDEX’s cash and cash equivalents were $568.2 million compared with $620.8 million at the end of fourth-quarter 2024. Long-term borrowings (net) were $1.85 billion compared with $1.9 billion at the end of fourth-quarter 2024.
In the first six months of 2025, IDEX generated net cash of $267.4 million from operating activities, down 7.9% from the year-ago period. Capital expenditures were $29.1 million compared with $35.9 million in the first six months of 2024. In the same period, free cash flow was $238.3 million, down 6.3% year over year.
IDEX paid out dividends totaling $105.9 million in the first six months of 2025, up 5.2% year over year.
IDEX’s Outlook
For the third quarter, IDEX anticipates adjusted earnings to be in the band of $1.90-$1.95 per share.
On a GAAP basis, IEX predicts earnings to be in the range of $1.54-$1.61 per share. It expects organic sales to increase in the range of 2-3% from the year-ago reading.
For 2025, the company anticipates adjusted earnings to be in the range of $7.85-$7.95 per share. The figure indicates an increase from earnings of $7.89 per share reported in 2024. On a GAAP basis, earnings are predicted to be in the band of $6.30-$6.44 per share.
Organic sales are predicted to increase approximately 1%.
Some other top-ranked companies are discussed below:
Flowserve Corporation (FLS - Free Report) presently sports a Zacks Rank of 1. FLS’ earnings surpassed the consensus estimate twice and missed on the other two occasions in the trailing four quarters. The average earnings surprise was 5.5%. In the past 60 days, the Zacks Consensus Estimate for Flowserve’s 2025 earnings has increased 1.6%.
ITT Inc. (ITT - Free Report) currently carries a Zacks Rank of 2. ITT has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 1.7%. In the past 60 days, the Zacks Consensus Estimate for ITT’s 2025 earnings has increased 0.9%.
RBC Bearings (RBC - Free Report) currently carries a Zacks Rank of 2. RBC outperformed the consensus estimate thrice in the preceding four quarters and missed once, with an average surprise of 4.7%. In the past 60 days, the Zacks Consensus Estimate for RBC’s 2025 earnings has inched up 1.4%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
IDEX Q2 Earnings Surpass Estimates, Sales Increase Year Over Year
Key Takeaways
IDEX Corporation’s (IEX - Free Report) second-quarter 2025 adjusted earnings of $2.07 per share surpassed the Zacks Consensus Estimate of $2.00. The bottom line was relatively flat on a year-over-year basis. Management projected adjusted earnings to be in the band of $1.95-$2.05 per share in the quarter.
IEX’s Revenue Details
IDEX’s net sales of $865.4 million beat the Zacks Consensus Estimate of $857 million. The top line increased 7% year over year. Organic sales increased 1% year over year. While acquisitions/divestitures had a positive impact on sales of 5%, organic sales and foreign currency translation had a positive impact of 1% each on sales.
IEX reports net sales under three business segments, the results of which are discussed below:
Net sales from the Fluid & Metering Technologies segment totaled $310.9 million, down 3% year over year. Our estimate for segmental net sales was $312.2 million. Organic sales decreased 2% year over year. Acquisitions/divestitures had an adverse impact on sales of 2%, while foreign currency translation had a positive impact of 1% on sales.
Net sales from the Health & Science Technologies segment totaled $365.3 million, up 20% year over year. Our estimate for segmental net sales was $355.6 million. Organic sales increased 4% year over year. Acquisitions/divestitures and foreign currency translation had a positive impact of 15% and 1%, respectively, on sales.
Net sales from the Fire & Safety/Diversified Products segment totaled $191.5 million, which increased 3% year over year. Our estimate for segmental net sales was $188.4 million. Organic sales increased 2% on a year-over-year basis, while foreign currency translation had a favorable impact of 1% on sales.
IDEX Corporation Price, Consensus and EPS Surprise
IDEX Corporation price-consensus-eps-surprise-chart | IDEX Corporation Quote
IDEX’s Margin Profile
IDEX’s cost of sales increased 7.4% year over year to $473.2 million. The adjusted gross profit was $392.2 million, up 6.9% year over year. The adjusted gross margin was 45.3% compared with 45.4% in the year-ago quarter.
Selling, general and administrative expenses increased 11.4% year over year to $203.6 million. Adjusted EBITDA was $237.2 million, up 5.7% from the year-ago quarter figure. The adjusted EBITDA margin decreased 40 bps year over year to 27.4%.
The operating income was $187.9 million, up 2.8% year over year. The operating margin was 21.7%, down 90 bps year over year. Interest expenses (net) increased 92.6% year over year to $15.6 million.
Balance Sheet and Cash Flow of IDEX
While exiting the second quarter, IDEX’s cash and cash equivalents were $568.2 million compared with $620.8 million at the end of fourth-quarter 2024. Long-term borrowings (net) were $1.85 billion compared with $1.9 billion at the end of fourth-quarter 2024.
In the first six months of 2025, IDEX generated net cash of $267.4 million from operating activities, down 7.9% from the year-ago period. Capital expenditures were $29.1 million compared with $35.9 million in the first six months of 2024. In the same period, free cash flow was $238.3 million, down 6.3% year over year.
IDEX paid out dividends totaling $105.9 million in the first six months of 2025, up 5.2% year over year.
IDEX’s Outlook
For the third quarter, IDEX anticipates adjusted earnings to be in the band of $1.90-$1.95 per share.
On a GAAP basis, IEX predicts earnings to be in the range of $1.54-$1.61 per share. It expects organic sales to increase in the range of 2-3% from the year-ago reading.
For 2025, the company anticipates adjusted earnings to be in the range of $7.85-$7.95 per share. The figure indicates an increase from earnings of $7.89 per share reported in 2024. On a GAAP basis, earnings are predicted to be in the band of $6.30-$6.44 per share.
Organic sales are predicted to increase approximately 1%.
IEX’s Zacks Rank & Other Key Picks
The company currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some other top-ranked companies are discussed below:
Flowserve Corporation (FLS - Free Report) presently sports a Zacks Rank of 1. FLS’ earnings surpassed the consensus estimate twice and missed on the other two occasions in the trailing four quarters. The average earnings surprise was 5.5%. In the past 60 days, the Zacks Consensus Estimate for Flowserve’s 2025 earnings has increased 1.6%.
ITT Inc. (ITT - Free Report) currently carries a Zacks Rank of 2. ITT has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 1.7%. In the past 60 days, the Zacks Consensus Estimate for ITT’s 2025 earnings has increased 0.9%.
RBC Bearings (RBC - Free Report) currently carries a Zacks Rank of 2. RBC outperformed the consensus estimate thrice in the preceding four quarters and missed once, with an average surprise of 4.7%. In the past 60 days, the Zacks Consensus Estimate for RBC’s 2025 earnings has inched up 1.4%.